BE826568A - Procede de preparation de vaccins vivants contre la varicelle - Google Patents
Procede de preparation de vaccins vivants contre la varicelleInfo
- Publication number
- BE826568A BE826568A BE2054201A BE2054201A BE826568A BE 826568 A BE826568 A BE 826568A BE 2054201 A BE2054201 A BE 2054201A BE 2054201 A BE2054201 A BE 2054201A BE 826568 A BE826568 A BE 826568A
- Authority
- BE
- Belgium
- Prior art keywords
- vaccines against
- live vaccines
- preparing live
- against chickenpox
- chickenpox
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2931874A JPS5341202B2 (da) | 1974-03-12 | 1974-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE826568A true BE826568A (fr) | 1975-09-12 |
Family
ID=12272859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2054201A BE826568A (fr) | 1974-03-12 | 1975-03-12 | Procede de preparation de vaccins vivants contre la varicelle |
Country Status (5)
Country | Link |
---|---|
US (1) | US3985615A (da) |
JP (1) | JPS5341202B2 (da) |
BE (1) | BE826568A (da) |
FR (1) | FR2263786B1 (da) |
GB (1) | GB1457382A (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1981002107A1 (en) * | 1980-01-25 | 1981-08-06 | Wistar Inst | Highly attenuated varicella virus vaccine and production thereof |
US4315914A (en) * | 1980-04-04 | 1982-02-16 | Seiji Arakawa | Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof |
NZ220645A (en) * | 1986-06-20 | 1989-10-27 | Merck & Co Inc | Modified varicella-zoster virus and its cultivation |
IL86180A (en) * | 1987-05-04 | 1992-08-18 | Merck & Co Inc | Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines |
AU4392193A (en) * | 1992-06-04 | 1993-12-30 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
US5360736A (en) * | 1992-06-04 | 1994-11-01 | Merck & Co., Inc. | Process for attenuated varicella zoster virus vaccine production |
JP4562812B2 (ja) | 1992-07-17 | 2010-10-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 帯状疱疹の予防または水痘関連ヘルペス後神経痛の緩和方法 |
KR0177323B1 (ko) * | 1996-02-16 | 1999-04-01 | 성재갑 | 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법 |
DE69729996T2 (de) * | 1996-05-15 | 2005-08-25 | The Research Foundation For Microbial Diseases Of Osaka University, Suita | Methode zur identifizierung von attenuiertem varicella virus vom stamm oka oder von einem davon abstammenden stamm |
US6051238A (en) * | 1996-12-20 | 2000-04-18 | Merck & Co., Inc. | Stabilizers for lyophilized mumps vaccines |
GB9804632D0 (en) | 1998-03-05 | 1998-04-29 | Cantab Pharma Res | Virus preparations and methods |
GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
KR20010043009A (ko) * | 1999-02-25 | 2001-05-25 | 무타이 마사히꼬 | 약독수증 바이러스 오카주의 유전자 62와 이 유전자 62를이용하는 약독생수증 백신용 바이러스주의 동정방법 |
US6528066B1 (en) | 1999-09-14 | 2003-03-04 | University Of Iowa Research Foundation | Variant varicella-zoster viruses and methods of use |
WO2004042031A2 (en) * | 2002-11-05 | 2004-05-21 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Safer attenuated virus vaccines with missing or diminished latency of infection |
WO2006012092A2 (en) * | 2004-06-29 | 2006-02-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Safer attenuated virus vaccines with missing or diminished latency of infection |
US7344839B2 (en) * | 2004-12-23 | 2008-03-18 | Aurx, Inc. | Virus preparations and methods |
GB0504436D0 (en) | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
WO2008079539A2 (en) | 2006-11-09 | 2008-07-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Recombinant herpesvirus with diminished latency and methods of using same |
JP5279504B2 (ja) | 2006-11-17 | 2013-09-04 | 一般財団法人阪大微生物病研究会 | 神経伸長促進剤および伸長阻害剤 |
CN101967466A (zh) | 2009-07-28 | 2011-02-09 | 新泽西医学院 | Orf7缺陷型水痘病毒株、含有该毒株的疫苗及其应用 |
UA112970C2 (uk) | 2010-08-05 | 2016-11-25 | Мерк Шарп Енд Доме Корп. | Інактивований вірус вітряної віспи, спосіб його одержання і застосування |
EP2686423A4 (en) | 2011-03-14 | 2015-01-28 | Nat Res Council Canada | METHOD FOR PRODUCING VIRUSES IN CELLS |
WO2014043189A1 (en) | 2012-09-14 | 2014-03-20 | The Regents Of The University Of Colorado, A Body Corporate | Conditionally replication deficient herpes viruses and use thereof in vaccines |
-
1974
- 1974-03-12 JP JP2931874A patent/JPS5341202B2/ja not_active Expired
-
1975
- 1975-03-11 FR FR7507594A patent/FR2263786B1/fr not_active Expired
- 1975-03-11 GB GB1007475A patent/GB1457382A/en not_active Expired
- 1975-03-12 BE BE2054201A patent/BE826568A/xx not_active IP Right Cessation
- 1975-03-12 US US05/557,724 patent/US3985615A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US3985615A (en) | 1976-10-12 |
GB1457382A (en) | 1976-12-01 |
JPS50123817A (da) | 1975-09-29 |
JPS5341202B2 (da) | 1978-11-01 |
FR2263786B1 (da) | 1978-12-01 |
FR2263786A1 (da) | 1975-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE826568A (fr) | Procede de preparation de vaccins vivants contre la varicelle | |
BE805207A (fr) | Procede de preparation de compositions aromatisantes | |
BE797300A (fr) | Procede de preparation de vaccins adsorbes | |
BE858992A (fr) | Procede de preparation de vaccins | |
BE823677A (fr) | Procede de preparation de thiophosphates de dialkyle | |
FR2335235A1 (fr) | Procede de preparation de substances anti-tumorales | |
FR2295138A1 (fr) | Procede de preparation de bis-acetals de p-benzoquinones | |
FR2277804A1 (fr) | Procede de preparation de polyalcools et de leurs ethers et esters | |
CS191868B2 (en) | Method of preparing live virus vaccine | |
FR2274611A1 (fr) | Procede de preparation de sels de 2-cyano-2-hydroxy-iminoacetamide | |
BE813169A (fr) | Procede de preparation des 3-fluorocephalosporines | |
BE824612A (fr) | Procede de preparation de 3-aminophenols | |
BE824372A (fr) | Vaccins antigrippaux et procede de leur preparation | |
BE807056A (fr) | Procede de preparation de dialkylphosphines | |
BE833245A (fr) | Procede de preparation de la cefazoline | |
FR2273828A1 (fr) | Procede de preparation de produits de condensation uree-formaldehyde porteurs de groupes sulfo | |
BE763141A (fr) | Procede de preparation de dichloropropanols | |
FR2289536A1 (fr) | Procede de preparation de c | |
BE831786A (fr) | Vaccin contre la gravidite et procede de sa preparation | |
BE801697A (fr) | Procede de preparation des benzyl-monocetals | |
BE772448A (fr) | Procede de preparation d'un vaccin vivant contre la bursite infectieusedes poules | |
BE826237A (fr) | Procede de preparation de bischlorocarbonates de bispheno | |
BE820739A (fr) | Procede de preparation de monoesters phosphoriques aliphatiques | |
BE828230A (fr) | Procede de preparation de trimethyl-p-benzoquinone | |
BE837041A (fr) | Procede de preparation de derives 3-methylenecepham |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: RESEARCH FOUNDATION FOR NICROBIAL DISEASES OF OSA Effective date: 19950312 |